Avenue Therapeutics
Avenue Therapeutics is a New York-based specialty pharmaceutical company focused on the development and commercialization of therapies for neurologic diseases and acute care. Founded in 2015, the company pursues product candidates including intravenous tramadol for post-operative pain, which is in Phase III trials, and therapies such as AJ201 for Kennedy's disease (spinal and bulbar muscular atrophy) and BAER-101 for epilepsy and panic disorders.
Top Regions
Top Stages
1 past transactions
Baergic Bio
Acquisition in 2022
Baergic Bio is a biopharmaceutical company dedicated to the development and commercialization of innovative therapeutics aimed at treating central nervous system disorders. The company is focused on addressing unmet medical needs in this field by creating novel treatment options that enhance patient outcomes. Through its commitment to advancing therapeutic solutions, Baergic Bio seeks to improve the quality of life for individuals affected by various CNS conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.